Earnings History Data for Roivant Sciences Ltd. (ROIV) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Roivant Sciences Ltd.
Roivant Sciences is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients. Roivant Sciences, formerly known as Montes Archimedes Acquisition Corp., is based in NEW YORK.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | PM | ROIV | Roivant Sciences Ltd. | 8,780 | -0.37 | -0.27 | -0.33 | Roivant Sciences GAAP EPS of -$0.25, revenue of $4.48M [11/12/2024 7:20 AM] |
11.63 | -0.18 (-1.48%) |
11.73 | -0.08 (-0.68%) |
8.47 - 13.06 | 4,039,860 | 3,560,000 | 10,452 | ||
|
||||||||||||||||||
| 08-08-2024 | PM | ROIV | Roivant Sciences Ltd. | 7,630 | -0.24 | -0.27 | -0.38 | Roivant Sciences GAAP EPS of $0.12 beats by $0.38, revenue of $55.13M beats by $25.54M [8/8/2024 7:32 AM] |
10.84 | 0.67 (6.54%) |
10.50 | 0.33 (3.24%) |
8.24 - 13.24 | 5,366,969 | 3,970,000 | 8,035 | ||
| 30-05-2024 | PM | ROIV | Roivant Sciences Ltd. | 8,730 | -0.28 | -0.31 | -0.20 | Roivant Sciences GAAP EPS of -$0.19 beats by $0.11, revenue of $28.93M misses by $2.01M [5/30/2024 7:08 AM] |
10.41 | -0.32 (-2.94%) |
10.84 | 0.11 (1.03%) |
8.24 - 13.24 | 9,489,143 | 4,430,000 | 3,394 | ||
| 13-02-2024 | PM | ROIV | Roivant Sciences Ltd. | 8,690 | -0.26 | -0.33 | -0.49 | Roivant Sciences GAAP EPS of $6.03 beats by $5.54, revenue of $37.14M beats by $7.32M [2/13/2024 7:06 AM] |
10.82 | -0.05 (-0.46%) |
10.95 | 0.08 (0.74%) |
6.59 - 13.24 | 4,925,396 | 5,340,000 | 23,331 | ||
| 13-11-2023 | PM | ROIV | Roivant Sciences Ltd. | 6,600 | -0.33 | -0.32 | -0.42 | Roivant Sciences GAAP EPS of -$0.40 misses by $0.09, revenue of $37.1M beats by $9.98M [11/13/2023 7:03 AM] |
9.04 | 0.23 (2.67%) |
8.75 | -0.06 (-0.68%) |
4.71 - 13.24 | 3,314,768 | 5,290,000 | 20,512 | ||
| 14-08-2023 | PM | ROIV | Roivant Sciences Ltd. | 8,640 | -0.38 | -0.26 | -0.48 | Roivant Sciences GAAP EPS of -$0.38 misses by $0.07, revenue of $21.62M misses by $2.87M [8/14/2023 7:27 AM] |
11.70 | 0.12 (1.08%) |
11.55 | -0.02 (-0.17%) |
2.87 - 12.01 | 3,099,127 | 3,030,000 | 80,850 | ||
| 28-06-2023 | PM | 7:00 AM ET (Jun 28) |
ROIV | Roivant Sciences Ltd. | 7,430 | -0.20 | -0.44 | -0.39 | Roivant Sciences GAAP EPS of -$0.20 beats by $0.18, revenue of $27.38M beats by $9.18M [6/28/2023 7:24 AM] |
10.05 | 1.00 (11.05%) |
9.26 | 0.21 (2.32%) |
2.87 - 10.83 | 7,774,099 | 8,430,000 | 12,433 | |
| 13-02-2023 | PM | 7:00 AM ET (Feb 13) |
ROIV | Roivant Sciences Ltd. | 5,840 | -0.49 | -0.36 | -0.41 | Roivant Sciences GAAP EPS of -$0.49 misses by $0.09, revenue of $17.05M beats by $2.27M [2/13/2023 7:39 AM] |
8.12 | 0.15 (1.82%) |
7.88 | -0.09 (-1.13%) |
2.52 - 10.00 | 1,501,855 | 2,870,000 | 11,212 | |
| 14-11-2022 | PM | 7:00 AM ET (Nov 14) |
ROIV | Roivant Sciences Ltd. | 3,650 | -0.42 | -0.41 | -0.87 | Roivant Sciences GAAP EPS of -$0.42 misses by $0.01, revenue of $12.53M beats by $6.83M [11/14/2022 7:30 AM] |
5.30 | 0.14 (2.71%) |
5.40 | 0.24 (4.65%) |
2.52 - 16.76 | 2,075,554 | 1,840,000 | 7,616 | |
| 15-08-2022 | PM | 6:10 AM ET (Aug 15) |
ROIV | Roivant Sciences Ltd. | 3,010 | -0.48 | -0.30 | -0.37 | Roivant Sciences GAAP EPS of -$0.48, revenue of $4.32M [8/15/2022 7:46 AM] |
4.22 | -0.14 (-3.32%) |
4.40 | 0.03 (0.69%) |
2.52 - 16.76 | 976,446 | 850,000 | 526 | |
| 28-06-2022 | PM | 7:00 AM ET (Jun 28) |
ROIV | Roivant Sciences Ltd. | 3,230 | -0.39 | -0.25 | 0.00 | Roivant Sciences GAAP EPS of -$0.39 misses by $0.09, revenue of $9.22M misses by $2.35M [6/28/2022 6:14 AM] |
4.68 | 0.01 (0.11%) |
4.95 | 0.27 (5.77%) |
2.52 - 16.76 | 596,055 | 1,130,000 | 15,617 | |
|
||||||||||||||||||
| 14-02-2022 | PM | 7:00 AM ET (Feb 14) |
ROIV | Roivant Sciences Ltd. | 5,030 | -0.41 | -0.23 | 0.00 | Roivant Sciences GAAP EPS of -$0.41 misses by $0.17, revenue of $24.34M [2/14/2022 7:03 AM] |
7.21 | 0.36 (5.26%) |
6.85 | 0.0 (0.00%) |
5.80 - 16.76 | 308,370 | 270,000 | 4,744 | |
| 15-11-2021 | PM | Before the open (Nov 15) |
ROIV | Roivant Sciences Ltd. | 5,360 | -0.87 | -0.45 | 0.00 | Roivant Sciences EPS beats by $0.15, beats on revenue [11/15/2021 7:33 AM] |
8.03 | -0.37 (-4.40%) |
8.59 | 0.19 (2.26%) |
5.80 - 10.87 | 508,173 | 370,000 | 271 | |